Study Stopped
Departmental priorities changed, partly due to COVID 19.
Ocular Imaging Study Using Advanced OCT
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 6, 2016
CompletedFirst Posted
Study publicly available on registry
July 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2021
CompletedApril 20, 2026
July 1, 2016
5.4 years
July 6, 2016
April 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders
2 years
Study Arms (1)
Retina abnormalities
Subjects with various retina vascular disorders
Eligibility Criteria
Subjects with retinal vascular abnormalities
You may qualify if:
- Any patient with abnormal retinal findings as determined by investigators.
You may not qualify if:
- Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
- Participants who are unable to maintain retinal fixation on a specified target.
- Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
- Patients with media opacity which preclude high quality imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stein Eye Institute/Geffen School of Medicine
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2016
First Posted
July 11, 2016
Study Start
July 1, 2016
Primary Completion
December 9, 2021
Study Completion
December 9, 2021
Last Updated
April 20, 2026
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share